ATE424926T1 - Abtrennung von ruthenium-nebenprodukten durch behandlung mit überkritischen flüssigkeiten - Google Patents

Abtrennung von ruthenium-nebenprodukten durch behandlung mit überkritischen flüssigkeiten

Info

Publication number
ATE424926T1
ATE424926T1 AT04813023T AT04813023T ATE424926T1 AT E424926 T1 ATE424926 T1 AT E424926T1 AT 04813023 T AT04813023 T AT 04813023T AT 04813023 T AT04813023 T AT 04813023T AT E424926 T1 ATE424926 T1 AT E424926T1
Authority
AT
Austria
Prior art keywords
ruthenium
sup
products
separation
treatment
Prior art date
Application number
AT04813023T
Other languages
English (en)
Inventor
F Gallou
S Saim
N K Yee
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of ATE424926T1 publication Critical patent/ATE424926T1/de

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/40—Regeneration or reactivation
    • B01J31/4015—Regeneration or reactivation of catalysts containing metals
    • B01J31/4023—Regeneration or reactivation of catalysts containing metals containing iron group metals, noble metals or copper
    • B01J31/4038—Regeneration or reactivation of catalysts containing metals containing iron group metals, noble metals or copper containing noble metals
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22—Organic complexes
    • B01J31/2204—Organic complexes the ligands containing oxygen or sulfur as complexing atoms
    • B01J31/2208—Oxygen, e.g. acetylacetonates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22—Organic complexes
    • B01J31/2265—Carbenes or carbynes, i.e.(image)
    • B01J31/2269—Heterocyclic carbenes
    • B01J31/2273—Heterocyclic carbenes with only nitrogen as heteroatomic ring members, e.g. 1,3-diarylimidazoline-2-ylidenes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
    • B01J31/2404—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/40—Regeneration or reactivation
    • B01J31/4015—Regeneration or reactivation of catalysts containing metals
    • B01J31/4069—Regeneration or reactivation of catalysts containing metals involving extraction with coordinating ionic liquids or supercritical fluids, e.g. CO2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J38/00—Regeneration or reactivation of catalysts, in general
    • B01J2038/005—Regeneration or reactivation of catalysts, in general involving supercritical treatment
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/50—Redistribution or isomerisation reactions of C-C, C=C or C-C triple bonds
    • B01J2231/54—Metathesis reactions, e.g. olefin metathesis
    • B01J2231/543—Metathesis reactions, e.g. olefin metathesis alkene metathesis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80—Complexes comprising metals of Group VIII as the central metal
    • B01J2531/82—Metals of the platinum group
    • B01J2531/821—Ruthenium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/54—Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/584—Recycling of catalysts

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Manufacture And Refinement Of Metals (AREA)
AT04813023T 2003-12-08 2004-12-06 Abtrennung von ruthenium-nebenprodukten durch behandlung mit überkritischen flüssigkeiten ATE424926T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52766803P 2003-12-08 2003-12-08

Publications (1)

Publication Number Publication Date
ATE424926T1 true ATE424926T1 (de) 2009-03-15

Family

ID=34676766

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04813023T ATE424926T1 (de) 2003-12-08 2004-12-06 Abtrennung von ruthenium-nebenprodukten durch behandlung mit überkritischen flüssigkeiten

Country Status (8)

Country Link
US (1) US7268211B2 (de)
EP (1) EP1699558B1 (de)
JP (1) JP2007513200A (de)
AT (1) ATE424926T1 (de)
CA (1) CA2547770A1 (de)
DE (1) DE602004019973D1 (de)
ES (1) ES2320776T3 (de)
WO (1) WO2005056182A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004274051A1 (en) * 2003-09-22 2005-03-31 Boehringer Ingelheim International Gmbh Macrocyclic peptides active against the hepatitis C virus
US7491794B2 (en) * 2003-10-14 2009-02-17 Intermune, Inc. Macrocyclic compounds as inhibitors of viral replication
EP1687021B1 (de) * 2003-11-20 2013-11-06 Boehringer Ingelheim International GmbH Verfahren zur entfernung von übergangsmetallen, insbesondere von metathese-reaktionsprodukten
EP1730167B1 (de) * 2004-01-21 2011-01-12 Boehringer Ingelheim International GmbH Makrocyclische peptide mit wirkung gegen das hepatitis-c-virus
JP2008513452A (ja) 2004-09-17 2008-05-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 超臨界流体中の閉環複分解方法
DE102005002336A1 (de) * 2005-01-17 2006-07-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Durchführung von kontinuierlichen Olefin-Ringschluss-Metathesen in komprimiertem Kohlendioxid
EP2103623A3 (de) 2005-07-25 2009-12-16 Intermune, Inc. Neue makrocyclische Inhibitoren der Replikation des Hepatitis-C-Virus
GEP20104956B (en) 2005-10-11 2010-04-12 Array Biopharma Inc Compounds for inhibiting hepatitis c viral replication and use thereof
GB0602663D0 (en) * 2006-02-09 2006-03-22 Univ Cardiff Removal of catalyst species
RU2008152171A (ru) 2006-07-05 2010-08-10 Интермьюн, Инк. (Us) Новые ингибиторы вирусной репликации гепатита с
AU2008251425A1 (en) 2007-05-10 2008-11-20 Array Biopharma, Inc. Novel peptide inhibitors of hepatitis C virus replication
ES2437147T3 (es) * 2008-02-04 2014-01-09 Idenix Pharmaceuticals, Inc. Inhibidores de serina proteasa macrocíclicos
EP2417134B1 (de) 2009-04-08 2017-05-17 Idenix Pharmaceuticals LLC. Macrocyclische serinproteaseinhibitoren
AR077712A1 (es) 2009-08-05 2011-09-14 Idenix Pharmaceuticals Inc Inhibidores de serina proteasa macrociclica
WO2012109398A1 (en) 2011-02-10 2012-08-16 Idenix Pharmaceuticals, Inc. Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating hcv infections
DE102015215387A1 (de) 2015-08-12 2017-02-16 Evonik Degussa Gmbh Verfahren zur Herstellung von Polyalkenameren für Verpackungsanwendungen

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840820A (en) * 1995-04-13 1998-11-24 The University Of North Carolina At Chapel Hill Olefin metathesis reactions in carbon dioxide medium
US5811515A (en) * 1995-06-12 1998-09-22 California Institute Of Technology Synthesis of conformationally restricted amino acids, peptides, and peptidomimetics by catalytic ring closing metathesis
JP2002506455A (ja) * 1997-06-27 2002-02-26 チバ スペシャルティ ケミカルズ ホールディング インコーポレーテッド 新しい触媒
US6323180B1 (en) 1998-08-10 2001-11-27 Boehringer Ingelheim (Canada) Ltd Hepatitis C inhibitor tri-peptides
AR022061A1 (es) 1998-08-10 2002-09-04 Boehringer Ingelheim Ca Ltd Peptidos inhibidores de la hepatitis c, una composicion farmaceutica que los contiene, el uso de los mismos para preparar una composicion farmaceutica, el uso de un producto intermedio para la preparacion de estos peptidos y un procedimiento para la preparacion de un peptido analogo de los mismos.
UA74546C2 (en) * 1999-04-06 2006-01-16 Boehringer Ingelheim Ca Ltd Macrocyclic peptides having activity relative to hepatitis c virus, a pharmaceutical composition and use of the pharmaceutical composition
US6608027B1 (en) * 1999-04-06 2003-08-19 Boehringer Ingelheim (Canada) Ltd Macrocyclic peptides active against the hepatitis C virus
GB2374071A (en) * 2001-04-06 2002-10-09 Swan Thomas & Co Ltd Hydrogenation reactions using supercritical fluids
CA2369711A1 (en) * 2002-01-30 2003-07-30 Boehringer Ingelheim (Canada) Ltd. Macrocyclic peptides active against the hepatitis c virus
US7119072B2 (en) * 2002-01-30 2006-10-10 Boehringer Ingelheim (Canada) Ltd. Macrocyclic peptides active against the hepatitis C virus
US20050075279A1 (en) * 2002-10-25 2005-04-07 Boehringer Ingelheim International Gmbh Macrocyclic peptides active against the hepatitis C virus
EP1615949A1 (de) * 2003-04-10 2006-01-18 Boehringer Ingelheim International GmbH Verfahren zur herstellung makrozyklischer verbindungen durch rutheniumkomplexkatalysierte metathesereaktion
CA2522205A1 (en) 2003-04-10 2004-10-28 Boehringer Ingelheim International Gmbh Process for preparing macrocyclic compounds
AU2004274051A1 (en) * 2003-09-22 2005-03-31 Boehringer Ingelheim International Gmbh Macrocyclic peptides active against the hepatitis C virus
EP1687021B1 (de) * 2003-11-20 2013-11-06 Boehringer Ingelheim International GmbH Verfahren zur entfernung von übergangsmetallen, insbesondere von metathese-reaktionsprodukten
JP4769200B2 (ja) * 2004-01-28 2011-09-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 遷移金属副生成物を含む反応溶液から遷移金属を除去する方法
JP2008513452A (ja) * 2004-09-17 2008-05-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 超臨界流体中の閉環複分解方法

Also Published As

Publication number Publication date
US20050154186A1 (en) 2005-07-14
US7268211B2 (en) 2007-09-11
EP1699558A1 (de) 2006-09-13
WO2005056182A1 (en) 2005-06-23
DE602004019973D1 (de) 2009-04-23
CA2547770A1 (en) 2005-06-23
EP1699558B1 (de) 2009-03-11
JP2007513200A (ja) 2007-05-24
ES2320776T3 (es) 2009-05-28

Similar Documents

Publication Publication Date Title
ATE424926T1 (de) Abtrennung von ruthenium-nebenprodukten durch behandlung mit überkritischen flüssigkeiten
Ogba et al. Recent advances in ruthenium-based olefin metathesis
Yee et al. Efficient large-scale synthesis of BILN 2061, a potent HCV protease inhibitor, by a convergent approach based on ring-closing metathesis
McCarver et al. Decarboxylative peptide macrocyclization through photoredox catalysis
Monfette et al. Equilibrium ring-closing metathesis
Paquette et al. A convenient method for removing all highly-colored byproducts generated during olefin metathesis reactions
DE60204772D1 (de) Verfahren zur herstellung eines oxirans
Ackermann et al. Ruthenium carbene complexes with imidazolin-2-ylidene ligands allow the formation of tetrasubstituted cycloalkenes by RCM
Vidavsky et al. Chelating alkylidene ligands as pacifiers for ruthenium catalysed olefin metathesis
Clavier et al. N‐heterocyclic carbene and phosphine ruthenium indenylidene precatalysts: a comparative study in olefin metathesis
Wang et al. Development of a robust ring-closing metathesis reaction in the synthesis of SB-462795, a cathepsin K inhibitor
Groso et al. Recent advances in the application of ring-closing metathesis for the synthesis of unsaturated nitrogen heterocycles
Olszewski et al. A new tool in the toolbox: Electron-withdrawing group activated ruthenium catalysts for olefin metathesis
WO2008010961A3 (en) Synthesis of terminal alkenes from internal alkenes and ethylene via olefin metathesis
Szczepaniak et al. High‐Performance Isocyanide Scavengers for Use in Low‐Waste Purification of Olefin Metathesis Products
Zhang et al. Peptide Fragment Coupling Using a Continuous‐Flow Photochemical Rearrangement of Nitrones
BR9508170A (pt) Processo para a separação de um catalisador de complexo de rodio-organofosfito solubilizado orgânico e ligante de organofosfito livre de uma mistura de reação de hidroformilação não aquosa
Dieltiens et al. Enyne Metathesis–Oxidation Sequence for the Synthesis of 2‐Phosphono Pyrroles: Proof of the “Yne‐then‐Ene” Pathway
MY137664A (en) Para-xylene process using perm-selective separations
Fandrick et al. Challenges and Opportunities for Scaling the Ring‐Closing Metathesis Reaction in the Pharmaceutical Industry
Hauser et al. Catalytic olefin epoxidation with a fluorinated organomolybdenum complex
Faulkner et al. Intramolecular metathesis versus Kharasch reactions using the Grubbs metathesis catalyst: towards catalyst economy
Moonen et al. Synthesis of 2-phosphonopyrroles via a one-pot RCM/oxidation sequence
Liu et al. Di (ethylene glycol) vinyl ether: a highly efficient deactivating reagent for olefin metathesis catalysts
Jungong et al. Formation of six-versus five-membered cyclic sulfones by C–H insertion

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1699558

Country of ref document: EP

REN Ceased due to non-payment of the annual fee